FDA Seeks Public Input To Craft Guidance For Nanotech Products
This article was originally published in The Rose Sheet
Executive Summary
FDA has scheduled a public meeting Sept. 8 to gather information about the possible effects of nanotechnology; input the agency receives could help shape future guidances, according to an Aug. 7 Federal Register notice
You may also be interested in...
Report Contests “Unsubstantiated” Nanotech Concerns, Touts Nano-Sunscreen
Current evidence suggests that nano-sized cosmetic ingredients pose no more risk to human health than their macro-sized counterparts, L'Oréal researchers maintain in a review published this month in Skin Pharmacology and Physiology
Pharma's Reform Bounce: How Big a Bounce Will $80 Bil. Buy?
Drug manufacturers made a pledge to contribute $80 bil. in a mix of savings and revenue-raising initiatives to help fund health reform. In return, they could see a wide range of new business depending on how you look at the numbers.
King's CorVu Gets Reluctant "No" From Advisory Committee
Despite voting that King's CorVu is not equivalent to its study comparator, Cardio-Renal panel sees bright future for the stress agent.